Lamotrigin Desitin (Lamotrigine)

Lamotrigine works by inhibiting voltage‑gated sodium channels on neurons, keeping them in an inactivated state. This reduces repetitive neuronal firing and limits the release of excitatory neurotransmitters such as glutamate, thereby decreasing seizure activity and helping to stabilize mood in bipolar disorder.

The dose of lamotrigine is individualized by the prescribing clinician based on the patient’s age, indication, renal and hepatic function, and any concomitant medications. No fixed regimen is provided here; the prescriber will set the appropriate starting dose and titration schedule.

Lamotrigine is classified as pregnancy category B, indicating that animal studies have not shown risk but adequate human data are lacking. It may be used during pregnancy if the benefit outweighs potential risk, and it can be excreted in breast milk. Physicians should discuss risks and benefits with the patient.

To request Lamotrigin Desitin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with carbamazepine or valproate, lamotrigine has a lower risk of weight gain and hepatic enzyme induction. It is generally better tolerated for mood stabilization but requires slower titration to avoid rash. Choice of therapy depends on the specific seizure type, comorbidities, and patient tolerance.

Lamotrigin Desitin should be stored at ambient temperature, below 25 °C, in its original container to protect it from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

Lamotrigin Desitin is taken orally. The tablet should be swallowed whole with water and can be taken with or without food. Patients should follow the dosing schedule prescribed by their healthcare professional and avoid crushing or chewing the tablet.

The most serious risks include severe skin reactions such as Stevens‑Johnson syndrome, toxic epidermal necrolysis, and DRESS (drug reaction with eosinophilia and systemic symptoms). Aseptic meningitis and rare hematologic abnormalities have also been reported. Immediate medical attention is required if any of these occur.

Patients with a known hypersensitivity to lamotrigine or any component of the formulation should avoid the product. Caution is also advised for individuals with severe hepatic impairment, and it should not be used in combination with contraindicated drugs such as certain enzyme inducers without appropriate dose adjustments.